PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 2037: Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time.

View Full Paper
NKNaurisha KapoorYÖYurday ÖzdemirJAJames V. Alvarez

Key Points

  • The aim is to visualize NRF2 dynamics at single-cell resolution to understand its role in therapy-resistant breast cancer cells.
  • Developed dual fluorescent reporters (Neh2-YFP and ARE-CFP) to track NRF2 protein stability and transcriptional activity.
  • Used confocal live-cell imaging on NMuMG mammary epithelial cells.
  • Validated the reporters with NRF2 activators and inhibitors to confirm functionality.
  • Planned to study NRF2 activity fluctuations during transitions to drug-resistant states.
  • Increased fluorescence observed with NRF2 activators like H2O2 and TBHQ.
  • Decreased fluorescence detected with NRF2 inhibitors such as ML385 and luteolin.
  • The dual-reporter system allows for distinguishing between protein stabilization and transcriptional activity of NRF2.
  • Anticipated to reveal noncanonical NRF2 activation mechanisms in breast cancer without Nfe2l2/Keap1 mutations.

Abstract

Abstract Tumor cell survival after therapy and the emergence of recurrent disease are major contributors to breast cancer mortality. NRF2, a master regulator of antioxidant and metabolic stress responses, is frequently activated in therapy-resistant and recurrent tumor cells, yet its regulation in the absence of canonical Nfe2l2/Keap1 mutations remains poorly understood. To enable real-time visualization of NRF2 dynamics, we developed a dual fluorescent reporter system to independently monitor NRF2 protein stability and transcriptional activity at single-cell resolution. The first reporter (Neh2-YFP) fuses YFP to the NRF2 Neh2 degron domain, providing a readout of KEAP1-dependent NRF2 protein turnover. The second reporter (ARE-CFP) places CFP under control of antioxidant response elements (AREs), enabling measurement of NRF2-dependent transcriptional output. Using confocal live-cell imaging in NMuMG mammary epithelial cells, we validated both reporters by demonstrating increased fluorescence after exposure to NRF2 activators (H2O2, TBHQ) and decreased signal with NRF2 inhibitors (ML385, luteolin). Building on this foundation, we will use the reporters to define how NRF2 activity fluctuates over short timescales and how these dynamics change during transitions from therapy-naïve to drug-tolerant, recurrent, or metastatic cell states. Because the two reporters disentangle protein stabilization from transcriptional competence, this system will also allow us to identify noncanonical mechanisms of NRF2 activation - such as altered kinase signaling or autophagy - specifically in breast cancer models lacking Nfe2l2/Keap1 mutations. Together, this dual-reporter platform enables dynamic, single-cell characterization of NRF2 regulation and will provide new insight into how NRF2-driven stress tolerance and metabolic adaptation contribute to tumor persistence, recurrence, and metastatic progression. Citation Format: Naurisha Kapoor, Yasemin Ceyhan Ozdemir, James V. Alvarez. Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2037.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kapoor et al. (2026) studied this question.

synapsesocial.com/papers/69d1fc70a79560c99a0a20ddhttps://doi.org/10.1158/1538-7445.am2026-2037
Ask AI
Helpful
Bookmark
Share
View Full Paper